A proposal for quicker approval of some new cell towers in Rancho Mirage is meant to boost coverage. But some residents have ...

Agios Pharmaceuticals shares rose Tuesday after the U.S. Food and Drug Administration granted priority review to the company's supplemental new drug application for mitapivat to treat sickle cell ...

On World Sickle Cell Day, a visit to Ward 16 reveals the daily reality of children and adolescents battling pain, long queues ...

The parents of a Bucknell University football player who died after collapsing during the first day of training camp in 2024 ...

The Nothing Phone 4b packs the biggest battery on a Nothing phone in India, but it also arrives with the brand's biggest ...

Modular nanorobot from University of Basel cut cancer cell viability to 16% by synthesizing drugs directly on cell surfaces ...

Devin Orr appeared in court where attorneys focused on the few moments before he pulled the trigger, killing a 12-year-old.

FDA's PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease CAMBRIDGE, Mass., July 07, 2026 (GLOBE NEWSWIR ...

A Las Vegas teacher who was once named educator of the year is facing more charges after investigators reportedly found child ...

Trade fair exhibit features 14 Allrounder machines, advanced robotic systems, turnkey production cells, and ALS host computer ...

FuelCell Energy (FCEL) stock rose 16% after announcing a partnership with Fit Energy USA to provide up to 380 MW of clean ...

The U.S. health secretary was a speaker at the Autism Health Summit, sponsored by a leading advocate for "regenerative medicines." ...